About.com Health

Share this article:
Company Profile
Silver Medal Winner for “Health Website of the Year” at the 2007 MM&M Awards, About.com Health is among the top health Web sites with more than 8 million visitors each month. About.com Health has the highest composition of women 25-54 and is the leader in many categories, like Arthritis, Pediatrics and Diet & Nutrition. (Source:Nielsen//NetRatings July 2007/@plan Summer 2007)

About.com is one the 15 most visited sites in the U.S. Each month, over 36 million unique visitors in the U.S. and 50 million worldwide trust About.com and its expert "Guides" to help them make more informed decisions on topics ranging from health, food, parenting and technology. Content on About.com is written by over 600 expert "Guides" who share their passions, expertise and how-to information in almost two million pieces of original content. This passion translates into reach. No other content site reaches more moms than About.com. We also reach more teens than MTV, more women than iVillage andmore men than ESPN. (Source: Nielsen//NetRatings July 2007)

Services and Offerings
Interactive opportunities include targeted media in over 600 categories, sponsorships, custom sites, promotions, mobile and podcasting.

If there is a way to reach a targeted consumer, About.com helps advertisers deliver those messages regardless of platform. Plus, our bedside manner is more like a visit from the family doctor, rather than a medical encyclopedia.
Share this article:
You must be a registered member of MMM to post a comment.
close

Next Article in Channel

MM&M EBOOK: PATIENT ACCESS

Patient access to pharmaceuticals is a tale of two worlds—affordability has improved for the majority, while the minority is hampered by cost, distribution and red tape. To provide marketers with a well-rounded perspective, MM&M presents this e-book chock full of key insights. Click here to access it.

More in Channel

Five things for pharma marketers to know: Monday, September 15

Five things for pharma marketers to know: ...

Pharma has sought 76 meetings with FDA over biosimilars; Gilead licenses Sovaldi to India generic drugmakers; Pfizer and Ranbaxy Lipitor lawsuit dismissed.

Liraglutide, aiming for new indication, gets new name

Liraglutide, aiming for new indication, gets new name

Why Novo Nordisk is choosing not to leverage Victoza's brand equity as it seeks a weight-loss indication for liraglutide.

Five things for pharma marketers to know: Friday, September 12

Five things for pharma marketers to know: Friday, ...

An FDA panel voted in favor of liraglutide for weight loss; Allergan investors backing an attempted takeover of the firm crossed a critical threshold; and 100 million health wearables are ...